Live Feeds
● LIVE Updated 1h ago · 20 sources tracked

U.S. provides experimental Ebola treatment for outbreak in Congo, bringing trials closer

The U.S. is sending experimental treatments to the Democratic Republic of Congo and Uganda to combat an Ebola outbreak. The WHO announced that trials for two potential treatments will begin next week. These efforts target the Bundibugyo strain, for which no known vaccine or treatment currently exists.

RSS Source map (18)

What changed

The U.S. has shipped experimental drugs and activated its highest-level response to the outbreak.

Live updates

  1. U.S. Ships Experimental Ebola Treatments for DRC Outbreak Trials

    The U.S. is sending experimental treatments to the Democratic Republic of Congo and Uganda to combat an Ebola outbreak. The WHO announced that trials for two potential treatments will begin next week. These efforts target the Bundibugyo strain, for which no known vaccine or treatment currently exists.

    What's confirmed:

    • The U.S. Department of Health and Human Services has sent experimental Ebola treatments to the Democratic Republic of Congo and Uganda.
    • The WHO announced trials for two potential Ebola treatments will start in the DRC next week.
    • U.S. health authorities activated the highest level of response to the Ebola outbreak in the Democratic Republic of Congo.
    • The current outbreak involves the Bundibugyo strain of Ebola.
    • There is no known vaccine or treatment for the Bundibugyo strain.

    Still unconfirmed:

    • The U.S. committed $50 million to develop countermeasures for the Bundibugyo Ebola strain.
    • The Africa Centres for Disease Control and Prevention is seeking $18 million for drug trials.
    • Ebola cases have breached 1,000.
    • Mapp and Gilead antivirals will be deployed in the DRC trial.
    confidence 95%